You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Survival

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pneumonia Trial (Lactoferrin, Pneumonia treatment)

Not yet recruiting
  • Pneumonia
  • (no location specified)
Jun 18, 2022

Stratification in Multiple Myeloma Based on Fluorescence Flow

Recruiting
  • Myeloma Multiple
  • fluorescence flow cytometry
  • Saint Petersburg, Russian Federation
    Boris V Afanasyev, MD, Prof.
Jul 19, 2022

Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)

Recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
Jan 6, 2023

Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer Trial in Birmingham (mirvetuximab soravtansine (MIRV; IMGN853))

Recruiting
  • Ovarian Cancer
  • +2 more
  • mirvetuximab soravtansine (MIRV; IMGN853)
  • Birmingham, Alabama
    University of Alabama at Birmingham Womens & Infants Center
Jun 30, 2022

The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer

Recruiting
  • Breast Cancer
  • Standard Therapy
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Jul 30, 2022

NSCLC Trial in Worldwide (RO7247669, Pembrolizumab, Paclitaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • Benowa, Queensland, Australia
  • +6 more
Mar 16, 2023

Clinical, Radiological, Histologic and Molecular Features

Recruiting
  • Meningeal Melanocytoma
  • +3 more
    • Nancy, France
      Nancy University Hospital Center
    Jul 31, 2023

    Cardiopulmonary Arrest With Successful Resuscitation, Educational Problems Trial in Foxboro (Video, AHA course)

    Recruiting
    • Cardiopulmonary Arrest With Successful Resuscitation
    • Educational Problems
    • Video
    • AHA course
    • Foxboro, Massachusetts
      Gillette Stadium
    Aug 7, 2023

    St. Jude Medical Product Longevity and Performance Registry

    Completed
    • Bradycardia
    • +2 more
    • Cardiac Rhythm Management device
    • Huntsville, Alabama
    • +79 more
    May 7, 2021

    Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

    Recruiting
    • Sickle Cell Disease
    • haploidentical stem cell transplant
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 18, 2022

    Colorectal Adenocarcinoma, Hepatic Metastases Trial in France (Irinotecan-Eluting Beads)

    Active, not recruiting
    • Colorectal Adenocarcinoma
    • Hepatic Metastases
    • Irinotecan-Eluting Beads
    • Blois, France
    • +15 more
    Aug 18, 2022

    Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

    Active, not recruiting
    • Acute Leukemia
    • +14 more
    • Duarte, California
      City of Hope Medical Center
    Nov 18, 2022

    Non-Hodgkin Lymphoma Trial in Dallas (Focal radiation therapy (RT))

    Recruiting
    • Non-Hodgkin Lymphoma
    • Focal radiation therapy (RT)
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 8, 2022

    Medium Cross-linked Polyethylene With and Without Vitamin E for

    Recruiting
    • Osteoarthritis, Knee
    • +4 more
    • UHMWPE with Vitamin E
    • UHMWPE without Vitamin E
    • Echirolles, Isere, France
    • +7 more
    Jul 22, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Portland (Carfilzomib, Isatuximab, Pomalidomide)

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jun 14, 2022

    Advanced or Metastatic NSCLC Trial in Worldwide (Datopotamab deruxtecan, Durvalumab, Carboplatin)

    Recruiting
    • Advanced or Metastatic NSCLC
    • Datopotamab deruxtecan
    • +4 more
    • Santa Ana, California
    • +15 more
    Dec 13, 2022

    Unresectable, Non-metastatic Hepatocellular Carcinoma Trial in China (biological, drug, procedure)

    Recruiting
    • Unresectable, Non-metastatic Hepatocellular Carcinoma
    • AK104
    • +2 more
    • Beijing, Beijing, China
    • +4 more
    Aug 11, 2022

    Lymphoma, Mantle-Cell, Recurrent Lymphoma, Mantle-Cell Trial in United States (ABT-199 and Ibrutinib Combination)

    Completed
    • Lymphoma, Mantle-Cell
    • Recurrent Lymphoma, Mantle-Cell
    • ABT-199 and Ibrutinib Combination
    • Duarte, California
    • +3 more
    May 22, 2022

    Acute Lymphoblastic Leukemia Trial in United Kingdom (Fludarabine, Melphalan, Alemtuzumab)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Birmingham, United Kingdom
    • +21 more
    Oct 14, 2021

    Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

    Not yet recruiting
    • Multiple Myeloma
    • Allogeneic Stem Cell Transplantation
    • CARTemis-1
    • Santander, Cantabria, Spain
    • +4 more
    Aug 1, 2023

    Non Small Cell Lung Cancer Trial in Canada (SBRT)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • SBRT
    • Vancouver, British Columbia, Canada
    • +6 more
    Apr 12, 2022

    Intrahepatic Cholangiocarcinoma Trial in Germany (Durvalumab, Tremelimumab)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • Dresden, Germany
    • +7 more
    Apr 13, 2022

    Trastuzumab Emtansine as Therapy in Chinese HER2 Positive

    Not yet recruiting
    • Breast Cancer
    • Trastuzumab emtansine
    • (no location specified)
    Jul 13, 2023

    Hepatocellular Carcinoma Trial in Bobigny (Lenvatinib Pill)

    Recruiting
    • Hepatocellular Carcinoma
    • Lenvatinib Pill
    • Bobigny, France
      NAHON
    Apr 6, 2022

    Advanced Squamous Non-Small-Cell Lung Cancer Trial (Trilaciclib, Carboplatin, Paclitaxel)

    Not yet recruiting
    • Advanced Squamous Non-Small-Cell Lung Cancer
    • (no location specified)
    Jun 11, 2023